Alternative Treatment Strategies for Stenotrophomonas Maltophilia Pneumonia

CompletedOBSERVATIONAL
Enrollment

110

Participants

Timeline

Start Date

July 21, 2022

Primary Completion Date

July 14, 2025

Study Completion Date

July 14, 2025

Conditions
Stenotrophomonas Maltophilia Infection
Interventions
DRUG

Antibiotic

We aim to examine differences in clinical outcomes and failure rates between standard and alternative treatment strategies such as minocycline (or moxifloxacin, ciprofloxacin, ceftazidime) alone or in combination with TMP-SMX, alternative TMP-SMX dosing regimens, or variations in durations of therapy for the treatment of S. maltophilia infections within Methodist Health System (MHS).

Trial Locations (1)

75201

Methodist Dallas Medical Center, Dallas

All Listed Sponsors
lead

Methodist Health System

OTHER